Neurizon Therapeutics Ltd News

Neurizon Therapeutics Ltd: Section 708A Cleansing Statement

Nov 29 00:17 ET

Neurizon Therapeutics Ltd: Application for quotation of securities - NUZ

Nov 29 00:06 ET

Neurizon Therapeutics Ltd: Updated Securities Trading Policy

Nov 18 20:13 ET

Neurizon Therapeutics Ltd: Correction to text positioning error in announcement

Nov 15 02:30 ET

Neurizon Therapeutics Ltd: Neurizon Presents Positive Preclinical Data on NUZ-001

Nov 14 17:59 ET

Neurizon Therapeutics Ltd: NUZ-001 Reduces Aggregation of Key ALS Disease Target

Nov 14 17:50 ET

Neurizon Therapeutics Ltd: Positive opinion received on OMPD for NUZ-001 in Europe

Nov 10 17:39 ET

Neurizon Therapeutics Ltd: Change of Director's Interest Notices x4

Nov 7 18:09 ET

Neurizon Therapeutics Ltd: Notification regarding unquoted securities - NUZ

Nov 6 23:02 ET

Neurizon Therapeutics Ltd: Notification regarding unquoted securities - NUZ

Nov 6 23:02 ET

Neurizon Therapeutics Ltd: Notification regarding unquoted securities - NUZ

Nov 6 22:36 ET

Neurizon Therapeutics Ltd: Section 708A Cleansing Statement

Nov 1 00:19 ET

Neurizon Therapeutics Ltd: Application for quotation of securities - NUZ

Nov 1 00:13 ET

Neurizon Therapeutics Ltd: Application for quotation of securities - NUZ

Nov 1 00:10 ET

Neurizon Therapeutics Ltd: Application for quotation of securities - NUZ

Nov 1 00:08 ET

Neurizon Therapeutics Ltd: Application for quotation of securities - NUZ

Nov 1 00:06 ET

Neurizon Therapeutics Ltd: Appendix 4C & Quarterly Update

Oct 30 18:21 ET

Neurizon Therapeutics Ltd: Neurizon Presents Phase 1 MEND Study Data at NEALS Meeting

Oct 24 18:55 ET

NEURIZON THERAPEUTICS LTD: PharmAust changes name to Neurizon Therapeutics

Oct 14 18:04 ET